947 related articles for article (PubMed ID: 29237448)
21. Responses to Treatment With Teriparatide in Patients With Atypical Femur Fractures Previously Treated With Bisphosphonates.
Watts NB; Aggers D; McCarthy EF; Savage T; Martinez S; Patterson R; Carrithers E; Miller PD
J Bone Miner Res; 2017 May; 32(5):1027-1033. PubMed ID: 28071822
[TBL] [Abstract][Full Text] [Related]
22. Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures.
Righetti M; Wach J; Desmarchelier R; Coury F
Joint Bone Spine; 2018 May; 85(3):365-367. PubMed ID: 29246529
[TBL] [Abstract][Full Text] [Related]
23. Atypical femoral fractures related to bisphosphonate use: A comprehensive review of 19 patients.
Şahin K; Ergin ON; Bayram S; Akgül T
Ulus Travma Acil Cerrahi Derg; 2019 Nov; 25(6):603-610. PubMed ID: 31701502
[TBL] [Abstract][Full Text] [Related]
24. Bisphosphonate therapy and atypical fractures.
Saleh A; Hegde VV; Potty AG; Lane JM
Orthop Clin North Am; 2013 Apr; 44(2):137-51. PubMed ID: 23544820
[TBL] [Abstract][Full Text] [Related]
25. Atypical diaphyseal femoral fractures: Considerations on surgical technique.
Spinelli MS; Marini E; Daolio PA; Piccioli A
Injury; 2019 Jul; 50 Suppl 2():S65-S69. PubMed ID: 30782394
[TBL] [Abstract][Full Text] [Related]
26. Effect of teriparatide (rh-PTH 1-34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study.
Iwata A; Kanayama M; Oha F; Hashimoto T; Iwasaki N
BMC Musculoskelet Disord; 2017 Apr; 18(1):148. PubMed ID: 28388910
[TBL] [Abstract][Full Text] [Related]
27. Factors Associated with Increased Healing Time in Complete Femoral Fractures After Long-Term Bisphosphonate Therapy.
Lim HS; Kim CK; Park YS; Moon YW; Lim SJ; Kim SM
J Bone Joint Surg Am; 2016 Dec; 98(23):1978-1987. PubMed ID: 27926679
[TBL] [Abstract][Full Text] [Related]
28. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use.
Weil YA; Rivkin G; Safran O; Liebergall M; Foldes AJ
J Trauma; 2011 Jul; 71(1):186-90. PubMed ID: 21610533
[TBL] [Abstract][Full Text] [Related]
29. Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment.
Zhang HY; Weng HL; Li M; Zhang J
Osteoporos Int; 2019 Nov; 30(11):2349-2354. PubMed ID: 31428823
[TBL] [Abstract][Full Text] [Related]
30. Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy.
Gomberg SJ; Wustrack RL; Napoli N; Arnaud CD; Black DM
J Clin Endocrinol Metab; 2011 Jun; 96(6):1627-32. PubMed ID: 21430030
[TBL] [Abstract][Full Text] [Related]
31. Alendronate-associated femoral insufficiency fractures and femoral stress reactions.
Wang K; Moaveni A; Dowrick A; Liew S
J Orthop Surg (Hong Kong); 2011 Apr; 19(1):89-92. PubMed ID: 21519086
[TBL] [Abstract][Full Text] [Related]
32. Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all.
Genest F; Seefried L
Osteoporos Int; 2018 Aug; 29(8):1815-1825. PubMed ID: 29774402
[TBL] [Abstract][Full Text] [Related]
33. [Is SSBT associated with atypical femoral fracture? SSBT isn't associated with atypical femoral fracture].
Soen S
Clin Calcium; 2012 Jun; 22(6):919-22. PubMed ID: 22653034
[TBL] [Abstract][Full Text] [Related]
34. [BISPHOSPHONATES AS A PREVENTATIVE TREATMENT FOR OSTEOPOROTIC HIP FRACTURES: A MIXED BLESSING].
Barak U; Rosenthal Y; Arami A; Kosashvili Y; Velkes S
Harefuah; 2017 Jul; 156(7):433-437. PubMed ID: 28786282
[TBL] [Abstract][Full Text] [Related]
35. Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.
Thompson RN; Phillips JR; McCauley SH; Elliott JR; Moran CG
J Bone Joint Surg Br; 2012 Mar; 94(3):385-90. PubMed ID: 22371548
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of teriparatide in in improving healing rates and bone-turnover markers of osteoporotic hip fracture: a meta-analysis.
Luo L; Lin J; Ma W; Fan J
J Pak Med Assoc; 2024 Apr; 74(4):741-751. PubMed ID: 38751272
[TBL] [Abstract][Full Text] [Related]
37. Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study.
Lim SJ; Yeo I; Yoon PW; Yoo JJ; Rhyu KH; Han SB; Lee WS; Song JH; Min BW; Park YS
Osteoporos Int; 2018 Nov; 29(11):2427-2435. PubMed ID: 30039251
[TBL] [Abstract][Full Text] [Related]
38. Atypical femoral fractures related to bisphosphonate treatment: issues and controversies related to their surgical management.
Koh A; Guerado E; Giannoudis PV
Bone Joint J; 2017 Mar; 99-B(3):295-302. PubMed ID: 28249967
[TBL] [Abstract][Full Text] [Related]
39. Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence?
Reddy SV; Gupta SK
Singapore Med J; 2012 Mar; 53(3):e52-4. PubMed ID: 22434305
[TBL] [Abstract][Full Text] [Related]
40. The advantages of tomosynthesis for evaluating bisphosphonate-related atypical femur fractures compared to radiography.
Petraszko A; Siegal D; Flynn M; Rao SD; Peterson E; van Holsbeeck M
Skeletal Radiol; 2016 May; 45(5):615-23. PubMed ID: 26861160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]